829.43
price up icon0.07%   0.59
after-market Dopo l'orario di chiusura: 829.44 0.01 +0.00%
loading

Regeneron Pharmaceuticals Inc Azioni (REGN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
8.42%
3,145.00
3,434.30 3,362.70 3,158.10 3,162.10
Operating Expenses
2.75%
2,393.60
2,461.40 2,251.70 2,141.60 2,215.40
Interest Income/Expense
12.02%
16.10
18.30 17.80 18.90 18.00
Benefits Costs and Expenses
6.89%
2,444.30
2,286.70 2,251.90 2,075.20 2,304.10
Costs And Expenses
2.75%
2,393.60
2,461.40 2,251.70 2,141.60 2,215.40
Operating Income/Loss
22.77%
751.40
972.90 1,111.00 1,016.50 946.70
Nonoperating Income/Loss
129.02%
-50.70
174.70 -0.20 66.40 -88.70
Income/Loss From Continuing Operations Before Tax
38.94%
700.70
1,147.60 1,110.80 1,082.90 858.00
Income Tax Expense/Benefit
77.50%
-21.30
-12.00 103.00 114.50 40.20
Income/Loss From Continuing Operations After Tax
37.74%
722.00
1,159.60 1,007.80 968.40 817.80
Net Income/Loss
37.74%
722.00
1,159.60 1,007.80 968.40 817.80
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
107.90K%
107.80
-0.10 106.30 107.00 107.10
Diluted Average Shares
115.10
- 113.40 113.90 114.00
Basic Earnings Per Share
38.48%
6.70
10.89 9.48 9.05 7.64
Diluted Earnings Per Share
38.53%
6.27
10.20 8.89 8.50 7.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$499.88
price up icon 5.73%
$602.47
price up icon 2.34%
$265.29
price down icon 1.73%
$110.97
price up icon 1.84%
$208.03
price up icon 0.38%
Capitalizzazione:     |  Volume (24 ore):